GSK IMMUNISATION GRANTS 

In 2020, the GSK Immunisation Grants will again be managed by the Public Health Association of Australia (PHAA) as part of the 17th National Immunisation Conference to be held in Perth from the 23 to 25 June 2020.

Four grants of $20,000 each, will be awarded to support innovation programs of activity that clearly aim to meet one or more of the following criteria in either childhood, adolescent and/or adult vaccines:

  • Improve access, coverage and/or timely delivery as per the Australian National Immunisation Program schedule;

  • Improve access, coverage and/or timely delivery for hard-to-reach populations (including geographically distant populations, new Australian immigrants, refugees, asylum seekers);

  • Utilise digital technology and/or social media to improve the Quality Use of Vaccines through innovation;

  • Improve access, coverage and/or timely delivery for indigenous populations;

  • Improve access, coverage and/or timely delivery for international travellers.

 

Objectives of the grants are to improve the update, compliance, timeliness and/or awareness of immunisation in Australia.The projects submitted for entry should be innovative, and adaptable by other immunisation groups. 

To download a copy of the GSK Immunisation Grants flyer please click here.

Important Dates

 

  • Call for abstracts open - Monday 13 January 2020

  • Call for abstracts close - Sunday 23 February 2020, 11:59pm AEDT

  • Notification of abstract submissions - Friday 15 March 2020

  • Finalist Applications open - Friday 15 March 2020

  • Finalist applications closed - Sunday 5 April 2020, 11:59pm AEST

  • Announcement of 2020 GSK Immunisation Grants - Wednesday 14 June 2020

GRANT APPLICATION PROCESS - NOW OPEN

​Phase 1 – Call for Abstracts


A Call for abstracts will take place for phase 1 of the Grants application process. Each response should be no longer than 300 to 500 words responding to one or more of the criteria. Once the call for abstracts closes, submissions will be reviewed and finalists notified. Finalised will then be asked to submit an application for the Grant in phase 2.


Abstract should be submitted using the Call for Abstracts Submission Form. 

 

Call for abstracts close Sunday 23 February 2020, at 11:59pm AEDT

To download a copy of the Call for Abstracts flyer please click here. 

Phase 2 – Finalists Applications    
Once finalists have been notified of their successful call for abstracts submission, they will be requested to submit the grant application.


The application must include a response to one or more of the criteria, as identified in the call for abstracts submission. Each response should be no more than 2000 words.


The application to be accompanied by at least one testimonial from a stakeholder, including examples of activities which have inspired the Application.


Applications will be submitted using the appropriate Application Form and be sent through with supporting documentation attached.


Grant winners will be notified at the 17th National Immunisation Conference Dinner on Wednesday 24 June 2020.
 

Recipient Benefits
 

The following benefits will be offered to Recipients of the 2020 GSK Immunisation Grants:

 

  • An award trophy, which is theirs to keep;

  • An award certificate;

  • A financial grant of $20,000 to be used towards achieving innovation and best practice in childhood and adult immunisation; and

  • A travel grant of up to $3,000 to attend and present at the next National Immunisation Conference in 2022.

 

Finalists
 

Finalists should use their best endeavours to attend or be represented at the Award Ceremony at the 17th National Immunisation Conference. 


Finalists will be invited to attend the Dinner with up to 2 tickets per finalist application provided complementary.
Presentation


The awards will be presented during the 17th National Immunisation Conference. The presentations will be made by the PHAA CEO and the sponsor of that award.


Monetary Award


Winners will receive a $20,000 grant prize. The grant prize will be divided up into two allotted amounts for project reporting purposes of the grant awards. 


Stage 1 - $15,000 of the grant funding will be awarded following the announcement of the winners via direct deposit within three (3) business days following the announcement to the nominated organisation/representative of the grant project identified on the finalist application form. 


Stage 2 - A following $5,000 will be provided once the final grant project report is submitted no later than Friday 30 April 2021. If the project report is not received by Friday 30 April 2021, the remaining $5,000 may be forfeited. 

Stage 3 – Travel and registration will be granted to the value of $3,000 for attending and presenting at the next National Immunisation Conference in 2022. A presentation and travel booking form will be sent to the GSK grant winners in February 2022 and to be returned by 5pm AEDT Friday 31 March 2022.


Reporting


Winners of the GSK Immunisation Grants will be required to submit a 1 year project report. A project report template will be provided and needs to be submitted no later than Friday 30 April 2021. On completion of the 1 year project report, the remaining $5,000 of grant funding will be provided. 

TERMS AND CONDITIONS

To view the 2020 GSK Immunisation Grants terms and conditions please click on the button below. 

2018 GSK Immunisation Grant winners

Contact Us: events@phaa.net.au 

© 2023 by Public Health Association of Australia.